Back

Hyperuricemia predicts worse prognosis in patients with chronic coronary syndrome after percutaneous coronary intervention: insights from Japanese real-world database using a storage system

27 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: Coronary artery disease - Epidemiology, prognosis, outcome 3 Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Naoyuki Akashi

Jichi Medical University Saitama Medical Center, Saitama (Japan)

6 More presentations in this session

Presentation thumbnail
Bleeding after percutaneous coronary intervention and selection of candidates for long-term dual antithrombotic treatment
Doctor P. Thrane (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Impact of BNP level in patients with heart failure on major bleeding events after percutaneous coronary intervention
Doctor Y. Otsuka (Kumamoto, JP)
Abstract Slides
Presentation thumbnail
Temporal trends, short- and long-term prognostic impact of pre-hospital delay times in ST elevation myocardial infarction - 20 years national data from the SWEDEHEART registry
Doctor M. Ericsson (Linkoping, SE)
Abstract Slides
Presentation thumbnail
The trajectory of Coronary-Artery-Bypass-Grafting patient phenotype through 23 years.
Doctor G. Pattakos (Athens, GR)
Abstract Slides
Presentation thumbnail
Association of lipoprotein(a)-levels with all-cause mortality following percutaneous coronary intervention
Doctor I. Dykun (Essen, DE)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery disease - Epidemiology, prognosis, outcome 3

The Event

Event poster

ESC Congress 2022

27 August 2022 11:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources